The researchers reviewed studies evaluating the effectiveness of minocycline in alleviating neuropathic pain because it reduces microglial activation, which suggests that it may reduce neuropathic pain.
In this study, researchers from the University of Pittsburgh share new findings that suggest women with type 1 diabetes have a shorter reproductive period and early menopause.
Study authors evaluated whether using an observational study that includes Medicare claims data could detect the proarrhythmic risk of medications known to prolong the QT interval.
Achieving glycemic control is important in preventing to prevent long-term type 1 diabetes complications. In this featured study, researchers investigate the use of hybrid closed-loop automated basal insulin delivery system.
Previous studies have shown that continuous subcutaneous insulin infusions can lead to improvements in clinical and quality of life benefits as compared to multiple daily injections of insulin. In this study, researchers led by Sanjeev Mehta, MD, MPH, of the Joslin Diabetes Center at Harvard University, test that concept in type 1 diabetes patients.
Patients with type 1 and type 2 diabetes have a high risk of cardiovascular disease (CVD), but now, a new study shows that type 1 diabetes patients are more susceptible to both cardiovascular and renal disease.
Incorporation of empagliflozin in a closed-loop, automated insulin pump for patients with type 1 diabetes may allow for the elimination of carbohydrate counting.
Researchers sought to identify whether there were any functional deficits in the developing brains of children with type 1 diabetes due to episodes of hyperglycemia.
At the Endocrine Society’s annual meeting, ENDO 2021, Seema Kumar from the Mayo Clinic presented a review covering the evaluation and assessment of pediatric obesity and type 2 diabetes mellitus.
